Evidence map›Paper›PMID 31830135›Full record

ArticlePLoS pathogens2019

Shigella sonnei infection of zebrafish reveals that O-antigen mediates neutrophil tolerance and dysentery incidence.

Vincenzo Torraca, Myrsini Kaforou, Jayne Watson, Gina M Duggan, Hazel Guerrero-Gutierrez, Sina Krokowski, Michael Hollinshead, Thomas B Clarke, Rafal J Mostowy, Gillian S Tomlinson and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Microbial genomics · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Science advances · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Shigella sonnei.Trends in microbiology · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Vincenzo TorracaSection of Microbiology, MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.ORCID 0000-0001-7340-0249
Myrsini KaforouDepartment of Paediatrics, Division of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0001-9878-4007
Jayne WatsonFaculty of Natural Sciences, Department of Life Sciences, MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.ORCID 0000-0002-4451-4113
Gina M DugganSection of Microbiology, MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.
Hazel Guerrero-GutierrezSection of Microbiology, MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.ORCID 0000-0003-1701-0208
Sina KrokowskiSection of Microbiology, MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.
Michael HollinsheadDivision of Virology, Department of Pathology, Cambridge University, Cambridge, United Kingdom.
Thomas B ClarkeSection of Microbiology, MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.
Rafal J MostowyMalopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.ORCID 0000-0002-4557-3748
Gillian S TomlinsonDivision of Infection and Immunity, University College London, London, United Kingdom.
Vanessa Sancho-ShimizuDepartment of Paediatrics, Division of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0002-3519-0727
Abigail ClementsFaculty of Natural Sciences, Department of Life Sciences, MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.ORCID 0000-0003-2285-777X
Serge MostowySection of Microbiology, MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.ORCID 0000-0002-7286-6503
Imperial College London · GBLondon School of Hygiene & Tropical Medicine · GBJagiellonian University · PLUniversity College London · GBUniversity of Cambridge · GB

Funding

Medical Research Council MR/N007727/1Medical Research Council MR/P028225/1MRF_ C0483Wellcome Trust 206444/Z/17/ZWellcome Trust 206508/Z/17/ZWellcome Trust WT097411MA
6 · The paper itself

Abstract

Shigella flexneri is historically regarded as the primary agent of bacillary dysentery, yet the closely-related Shigella sonnei is replacing S. flexneri, especially in developing countries. The underlying reasons for this dramatic shift are mostly unknown. Using a zebrafish (Danio rerio) model of Shigella infection, we discover that S. sonnei is more virulent than S. flexneri in vivo. Whole animal dual-RNAseq and testing of bacterial mutants suggest that S. sonnei virulence depends on its O-antigen oligosaccharide (which is unique among Shigella species). We show in vivo using zebrafish and ex vivo using human neutrophils that S. sonnei O-antigen can mediate neutrophil tolerance. Consistent with this, we demonstrate that O-antigen enables S. sonnei to resist phagolysosome acidification and promotes neutrophil cell death. Chemical inhibition or promotion of phagolysosome maturation respectively decreases and increases neutrophil control of S. sonnei and zebrafish survival. Strikingly, larvae primed with a sublethal dose of S. sonnei are protected against a secondary lethal dose of S. sonnei in an O-antigen-dependent manner, indicating that exposure to O-antigen can train the innate immune system against S. sonnei. Collectively, these findings reveal O-antigen as an important therapeutic target against bacillary dysentery, and may explain the rapidly increasing S. sonnei burden in developing countries.

Indexed as

AnimalsDysentery, BacillaryHumansNeutrophilsO AntigensShigella sonneiVirulenceZebrafishO Antigens

Identifiers

PMID31830135
PMCPMC6980646
OpenAlexW2995002754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.